Samsung Launches AI-Powered Health Assistant Beta Ahead of Galaxy Unpacked

Samsung has launched an AI-powered personal health assistant chatbot, called Health Assistant, in beta for eligible US users. The tool is fully integrated into Samsung Health and pulls data from a user's phone, Galaxy Watch, and Galaxy Ring. Samsung disclosed the launch to Bloomberg and published details on its US newsroom on July 21, 2026, one day ahead of its Galaxy Unpacked event scheduled for July 22 in London under the tagline "A New Shape Unfolds" (Engadget).
Health Assistant is opt-in and organized around five wellness pillars: sleep, activity, nutrition, mindfulness, and vitals. It draws on Samsung's personalized data engine, which incorporates calendar and smart home device data alongside sensor readings from wearables. Samsung has stated that the recommendations surfaced by Health Assistant were validated by a team of physicians and certified health coaches.
The company has drawn a clear boundary around the tool's clinical scope. Health Assistant will not offer medical advice, suggest treatments, or diagnose health conditions. That positioning is consistent with how consumer wearable makers have navigated the gap between wellness engagement and regulated medical software, and it matters: the line between a "wellness insight" and a "clinical recommendation" is where FDA scrutiny typically begins.
Alongside Health Assistant, Samsung introduced a sleep monitoring feature that tracks heart rate and blood oxygen levels and alerts users to significant shifts during sleep. The company is also rolling out three new composite metrics within Samsung Health: an Energy Score, a Heart Health Score, and a Fitness Index. These join a growing field of vendor-computed wellness indices that attempt to distill multi-sensor data into a single readable number, a pattern now standard across consumer health platforms.
The more consequential move may be on the clinical integration side. Samsung is developing a platform to let physicians access smartwatch data and monitor metrics such as blood pressure between clinic visits. That effort is reinforced by Samsung's acquisition of Xealth, a company that integrates wearable data with clinical records. The combination of a physician-facing platform and a clinical-data integration acquisition points toward Samsung positioning its hardware not just as a consumer wellness ecosystem but as a data source embedded in clinical workflows.
Samsung's own framing of the foldable category is characteristically direct: the Galaxy portfolio "has defined the foldable category." The Unpacked event in London is expected to showcase the next generation of foldable hardware, though the health announcements made the day prior signal where Samsung sees recurring software and services revenue developing. For a company whose device margins face continued pressure, health-focused subscription and clinical data services represent a different margin profile entirely.
The competitive landscape Samsung enters here is dense. Apple Health has offered AI-assisted insights and physician-facing data sharing for years, and Google's Fitbit platform continues to layer in generative-AI coaching. Samsung's differentiation rests on its end-to-end hardware stack (phone, watch, and ring), the clinical validation process it says it applied to Health Assistant's recommendations, and the Xealth acquisition for clinical-records integration. Whether that stack is sufficient to differentiate in a market where consumers rarely switch health platforms remains an open question.
I have watched this category evolve from simple step counters to multi-sensor platforms that surface trends most users would not catch on their own. The trajectory has been steady: more sensors, more data, more AI-mediated interpretation. Samsung's Health Assistant sits squarely on that curve. What would differentiate it is not the chatbot interface, which is becoming table stakes, but the physician-facing platform and the clinical-records bridge. If a user's Galaxy Watch blood pressure data lands in their physician's chart without manual export, that changes the utility of the device in a way that a conversational wellness coach does not.
The beta is limited to eligible US users. No broader rollout date has been specified.


